Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 April 2025 | Story Tshepo Tsotetsi
Congratulations to our UFS leaders of the future!

The University of the Free State (UFS) has officially wrapped up its April 2025 graduation season, closing a powerful two-week chapter marked by pride, perseverance, and purpose. Across both its Bloemfontein and Qwaqwa campuses, 7 994 graduates walked the stage, each one carrying with them a story, a struggle, and a celebration.

From Mandela Hall on the Qwaqwa Campus (4–5 April) to the Callie Human Centre on the Bloemfontein Campus (8–12 April), the energy was unmistakable. Applause thundered, gowns flowed, names were called with pride, and ululations filled the air. Some graduates clutched their hard-earned certificates with trembling hands. Others waved to proud families seated in the crowd. But in every moment, one thing was clear: this was not just a ceremony; it was a milestone.

This year, the UFS proudly conferred three honorary doctorates to individuals whose lives and work embody leadership, service, and scholarship:

  • Judge Raymond Zondo, former Chief Justice of South Africa, for his lifelong dedication to justice and transformation in the legal system;
  • Ms Joyce Siwani, social worker and activist, for her powerful legacy in children’s rights and community development; and
  • Prof Toyin Falola, world-renowned historian and scholar, for his outstanding contribution to African knowledge systems and the humanities.

 Alongside these honours, 18 Dean’s Medals were awarded to the highest achievers in each faculty. At the very top stood Jocelyn Smith, who received the Senate Medal – the university’s most prestigious academic award. Smith achieved the highest weighted average across all faculties and graduated with a Bachelor of Science Honours degree in Data Science from the Faculty of Natural and Agricultural Sciences.

But it was not just a celebration of titles. It was a celebration of people. Seventeen members of the Student Representative Council (SRC) also received their qualifications, proving that leadership and academic excellence go hand in hand. And, stepping out from behind lecture-hall podiums and office desks, several academic and support staff members crossed the stage, upgrading their qualifications and proving that learning never stops.

As the UFS journeys toward its future vision – Vision 130 – to be an institution of excellence, care, and impact by 2034, graduations like these serve as a reminder of the human heartbeat behind every strategy, goal, and milestone.

Now, as autumn leaves settle across the Free State, the UFS Class of 2024 walks into their future with heads high, hearts full, and stories that will continue to inspire.

Congratulations, Kovsies!

Watch as each of the honorary doctorate recipients reflects on what the recognition means to them:


WATCH: Dr Joyce Siwani

WATCH: Dr Raymond Zondo

WATCH: Prof Toyin Falola

“Today, I am receiving an honorary doctorate at a university that I never thought I would step into.”

On 9 April 2025, Joyce Siwani was honoured by the University of the Free State with an honorary doctorate in the Faculty of The Humanities, recognising her remarkable journey and contributions in the field of social work.

Watch her share in her own powerful words what this recognition means to her.

Former Chief Justice Raymond Zondo reflects on receiving his honorary doctorate from the University of the Free State Faculty of Law, highlighting the power of education and the urgent need for ethical leadership in Africa.

“Education is the only thing that can really make a meaningful difference to people who are poor, to those who want to change the conditions of living of their communities.”

Watch as Prof Toyin Falola reflects on what it means to receive an honorary doctorate from the University of the Free State Faculty of Law – awarded for his remarkable contributions to African knowledge systems, global scholarship, and decolonial thought.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept